Investing
Proceeds from Sale of Seagen Inc. Common Stock
Analysis
StatementCash Flow Statement
SectionInvesting
First reportedQ1 2021
Last reportedQ4 2025Feb 24, 2026
Metric ID:
mrk_proceeds_from_sale_of_seagen_stockHistorical Data
5 years
| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $1.15B | $0.00 | $0.00 |
| YoY Change | — | — | — | -100.0% | — |
Range$0.00 – $1.15B
Avg YoY Growth-100.0%
Median YoY Growth-100.0%
Proceeds from Sale of Seagen Inc. Common Stock at Other Companies
Frequently Asked Questions
- What is Merck & Co.'s proceeds from sale of seagen inc. common stock?
- Merck & Co. (MRK) reported proceeds from sale of seagen inc. common stock of $0.00 in Q4 2025.